Latest news with #DrLalPathLabs
Business Upturn
15 hours ago
- Business
- Business Upturn
Dr Lal PathLabs shares decline 2% as Amazon enters diagnostics segment with doorstep lab tests
By Aditya Bhagchandani Published on June 23, 2025, 09:15 IST Shares of Dr Lal PathLabs fell over 2% to Rs 2,849.00 on Monday after Amazon India announced the launch of its diagnostics service in collaboration with Orange Health Labs. The new offering is expected to intensify competition in the organised diagnostics and pathology services space. Amazon Diagnostics, rolled out under the newly consolidated Amazon Medical umbrella, will provide customers across major cities such as Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad with access to over 800 diagnostic tests and doorstep sample collection within 60 minutes. This aggressive entry could potentially disrupt pricing and margins for existing players like Dr Lal PathLabs and Metropolis Healthcare. Despite the stock's dip today, Dr Lal PathLabs recently reported strong Q4 FY25 earnings. Net profit surged 81.4% YoY to Rs 155 crore, with PAT margin improving to 25.8%. Revenue rose 10.5% YoY to Rs 603 crore, driven by increased testing volumes and operational efficiency. However, the market reaction suggests concerns about long-term competitive pressure from tech giants like Amazon entering the healthcare segment with integrated services and scale advantages. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.
Mint
15 hours ago
- Business
- Mint
Metropolis, Dr Lal PathLabs shares dip up to 3% as Amazon enters diagnostic market
Diagnostic stocks including Metropolis Healthcare, Dr Lal PathLabs, Krsnaa Diagnostics, and Thyrocare Technologies came under pressure during Monday's trade (June 23), falling up to 3% intraday as investor sentiment turned cautious after Amazon launched home diagnostic services, intensifying competition in India's $15 billion diagnostics market. On Sunday, Amazon India announced the launch of Amazon Diagnostics — an at-home service that allows customers to book lab tests, schedule and track appointments, and access digital reports via the Amazon app — marking an expansion of its medical offerings beyond online pharmacy and teleconsultations. The service, being offered in collaboration with Orange Health Labs, will be available in Bengaluru, Delhi, Gurgaon, Noida, Mumbai, and Hyderabad, across over 450 PIN codes, the company said in a statement. Last week, the company announced that it would invest over $233 million in 2025 to enhance its India operations. While the healthcare foray is in line with Amazon's global strategy, India is the only country that has diagnostic services currently. Amazon is not the only digital player entering diagnostics. Online pharmacies like Tata 1mg, Apollo 24/7, Pharmeasy, and Netmeds have all expanded their offerings beyond medicines to include diagnostics. Industry experts believe that the diagnostics space, which has largely been unorganized and fragmented in India so far, holds significant potential due to changing consumer preferences as well as higher profit margins. 'There are three primary revenue streams in the B2C health tech space—teleconsultation, diagnostics, and pharmaceutical distribution. Of these, diagnostics remains the most significant profit pool,' Tarun Sharma, senior fund manager and healthcare and consumer strategy head at 360 ONE Asset, said. 'So, this space continues to attract competition, which means constant pricing risk. At the same time, consumers are becoming increasingly discerning about the accuracy of reports and the overall quality of their experience,' he added. Disclaimer: The views and recommendations given in this article are those of individual analysts. These do not represent the views of Mint. We advise investors to check with certified experts before making any investment decisions.
National Post
04-06-2025
- Health
- National Post
Did controversial boxer Imane Khelif know about being biologically ‘male' at Olympics?
Article content Earlier this week, a medical report from 2023 was leaked that allegedly shows Khelif biologically is 'male.' Article content The document, which initially was published by 3 Wire Sports, summarizes the findings on the Algerian boxer as 'abnormal,' stating: 'Chromosome analysis reveals male karyotype.' A karyotype refers to an individual's complete set of chromosomes, with Khelif's having been reported by the International Boxing Association (IBA) as XY, the male pattern. Article content Alan Abrahamson, an American journalist who first reported last year that the International Olympic Committee (IOC) had been warned about Khelif's now-published medical report, produced the result of a March 2023 test carried out in New Delhi. The results of the test caused the boxer's disqualification from that year's boxing championships. Article content The Algerian was part of a firestorm in Paris over the reported gender test from the 2023 event, but was allowed to compete in the women's event in Paris and went on to dominate the competition. Article content Article content The test results reportedly were carried out at Dr Lal PathLabs in New Delhi, which is accredited by the American College of Pathologists and certified by the Swiss-based International Organization for Standardization. Article content 'The truth was always there,' Davies told GB News. 'We all knew that this person had two positive sex screening tests. And the people that are to blame for all of this are the IOC. Article content 'If you look back to those press conferences during the Olympic Games last summer, the things that Thomas Bach was saying are never excusable. They allowed male-on-female violence for the whole world to watch. Article content 'The fact that they turned around and said that those tests that they had been informed about, a year prior, were not legitimate — when they were performed and accredited by the U.S. College of Pathology.
National Post
02-06-2025
- Health
- National Post
Leaked medical report states controversial Olympic boxer has 'male' chromosomes
Article content No competitor could stop Imane Khelif at the Paris Olympics, but a leaked medical report might have floored any hope the boxer has of defending their gold medal in Los Angeles. Article content Article content The document, which initially was published by 3 Wire Sports, summarizes the findings on the Algerian boxer as 'abnormal,' stating: 'Chromosome analysis reveals male karyotype.' A karyotype refers to an individual's complete set of chromosomes, with Khelif's having been reported by the International Boxing Association (IBA) as XY, the male pattern. Article content Alan Abrahamson, an American journalist who first reported last year that the International Olympic Committee (IOC) had been warned about Khelif's now-published medical report, produced the result of a March 2023 test carried out in New Delhi. The results of the test caused the boxer's disqualification from that year's boxing championships. Article content The Algerian was part of a firestorm in Paris over the reported gender test from the 2023 event, but was allowed to compete in the women's event in Paris and went on to dominate the competition. Article content The test results reportedly were carried out at Dr Lal PathLabs in New Delhi, which is accredited by the American College of Pathologists and certified by the Swiss-based International Organization for Standardization. Article content This latest revelation contradicts the claims of IOC spokesman Mark Adams, who had described the results as 'ad hoc' and 'not legitimate' during last year's Games. Article content
Daily Mail
02-06-2025
- Health
- Daily Mail
Leaked medical report 'proves Imane Khelif is a biological male' in bombshell claim about Olympic boxer
Results from boxer Imane Khelif's sex test at the 2023 World Championships have reportedly emerged, with the medical report allegedly suggesting the controversial Olympic champion is a biological male, according to various outlets. The alleged results comes less than two days after World Boxing ruled that Khelif would need to undergo sex screening to be eligible for any future appearances in female events. Khelif won a women's boxing gold medal representing Algeria boxing at the Paris Games. Khelif was deemed eligible to compete in France despite having more than a year's previous knowledge about the the test, with IOC president Thomas Bach previously questioning the test's legitimacy. 'Chromosome analysis reveals male karyotype,' the document, seen by 3 Wire Sports via Telegraph Sport, states. The results reportedly have a date of being collected of March 17, 2023 - the same year that Khelif was disqualigied by the International Boxing Association (IBA), the former governing body for the sport for allegedly failing gender eligibility tests. The alleged document is marked with the letterhead of Dr Lal PathLabs in New Delhi, a laboratory which is accredited by the American College of Pathologists and certified by the International Organisation for Standardisation. The report was initially published by the journalist Alan Abrahamson, who first brought reports of Khelif's alleged failed gender eligibility test to public attention at the Paris Games. Mail Sport has contacted Khelif's representatives for comment. Khelief has previously stated that she planned to defend her gold medal at the Los Angeles Olympics in three years time. World Boxing does have some Olympic authority, as they have been announced to provisionally run testing for the Los Angeles games, with any person over 18 required to undergo PCR testing to determine their sex. The governing body said the PCR test is a laboratory technique used to detect specific genetic material, with the SRY gene revealing the presence of the Y chromosome, which is an indicator of biological sex. The test can be a be conducted by nasal/mouth swab, saliva or blood. The governing body said the testing will be part of a new policy on 'Sex, Age and Weight', which it claims will a safe and competitive playing field. World Boxing revealed the contents of a letter sent to the Algerian Boxing Federation, confirming Khelif is unable to compete in the female category at the Eindhoven Box Cup or any World Boxing event under she undergoes sex testing. 'Imane Khelif may not participate in the female category at the Eindhoven Box Cup, 5-10 June 2025 and any World Boxing event until Imane Khelif undergoes genetic sex screening in accordance with World Boxing's rules and testing procedures,' the letter read. 'In accordance with the World Boxing Statutes, amendments to the Competition Rules are typically made by Congress. However, under special or emergency circumstances, the World Boxing Executive Board holds the authority to make immediate amendments when a rule is deemed no longer functional or when evolving conditions necessitate a change. 'In May 2025, the Executive Board exercised this authority and adopted new eligibility criteria for participation in sex-specific boxing categories. These new eligibility rules were developed with the express purpose of safeguarding athletes in combat sports, particularly given the physical risks associated with Olympic-style boxing. 'Please be advised that, per World Boxing policy, '…in the event the athlete's sex certification is challenged by the athlete's federation or by World Boxing, the athlete shall be ineligible to compete until the dispute is resolved…' Khelif was not the only controversial boxer in Paris, as Taiwan's Lin Yu-ting also won a gold medal in women's boxing despite having been banned by the IBA in 2023.
